XML 150 R60.htm IDEA: XBRL DOCUMENT
v3.24.0.1

Investments in Other Entities - Schedule of Equity Method Investments (Details) - USD ($) $ in Thousands | 12 Months Ended
--- | ---
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021
Equity Method Investments [Roll Forward] |  |  |
Beginning Balance | $ 40,299 | $ 41,715 |
Initial Investment | 325 |  |
Allocation of Net Income (Loss) | 5,579 | 5,622 | $ (4,306)
Funding Reclassified to Loan Receivable |  | (2,125) |
Funding | 700 | 2,105 |
Adjustment to fair value | 3,351 |  |
Entity Consolidated |  | (6,418) |
Distribution | (24,480) | (600) |
Ending Balance | $ 25,774 | $ 40,299 | 41,715
LaSalle Medical Associates – IPA Line of Business |  |  |
Schedule of Equity Method Investments [Line Items] |  |  |
% of Ownership | 25.00% | 25.00% |
Equity Method Investments [Roll Forward] |  |  |
Beginning Balance | $ 5,684 | $ 3,034 |
Initial Investment | 0 |  |
Allocation of Net Income (Loss) | 4,182 | 4,775 |
Funding Reclassified to Loan Receivable |  | (2,125) |
Funding | 0 | 0 |
Adjustment to fair value | 0 |  |
Entity Consolidated |  | 0 |
Distribution | 0 | 0 |
Ending Balance | $ 9,866 | $ 5,684 | 3,034
Pacific Medical Imaging & Oncology Center, Inc. |  |  |
Schedule of Equity Method Investments [Line Items] |  |  |
% of Ownership | 40.00% | 40.00% |
Equity Method Investments [Roll Forward] |  |  |
Beginning Balance | $ 1,878 | $ 1,719 |
Initial Investment | 0 |  |
Allocation of Net Income (Loss) | (187) | 159 |
Funding Reclassified to Loan Receivable |  | 0 |
Funding | 0 | 0 |
Adjustment to fair value | 0 |  |
Entity Consolidated |  | 0 |
Distribution | 0 | 0 |
Ending Balance | $ 1,691 | $ 1,878 | 1,719
531 W. College, LLC * |  |  |
Schedule of Equity Method Investments [Line Items] |  |  |
% of Ownership | 50.00% | 50.00% |
Equity Method Investments [Roll Forward] |  |  |
Beginning Balance | $ 17,281 | $ 17,230 |
Initial Investment | 0 |  |
Allocation of Net Income (Loss) | (508) | (619) |
Funding Reclassified to Loan Receivable |  | 0 |
Funding | 700 | 670 |
Adjustment to fair value | 91 |  |
Entity Consolidated |  | 0 |
Distribution | (17,564) | 0 |
Ending Balance | $ 0 | $ 17,281 | 17,230
One MSO, LLC * |  |  |
Schedule of Equity Method Investments [Line Items] |  |  |
% of Ownership | 50.00% | 50.00% |
Equity Method Investments [Roll Forward] |  |  |
Beginning Balance | $ 2,718 | $ 2,910 |
Initial Investment | 0 |  |
Allocation of Net Income (Loss) | 938 | 408 |
Funding Reclassified to Loan Receivable |  | 0 |
Funding | 0 | 0 |
Adjustment to fair value | 3,260 |  |
Entity Consolidated |  | 0 |
Distribution | (6,916) | (600) |
Ending Balance | $ 0 | $ 2,718 | 2,910
CAIPA MSO, LLC |  |  |
Schedule of Equity Method Investments [Line Items] |  |  |
% of Ownership | 30.00% | 30.00% |
Equity Method Investments [Roll Forward] |  |  |
Beginning Balance | $ 12,738 | $ 11,992 |
Initial Investment | 0 |  |
Allocation of Net Income (Loss) | 922 | 746 |
Funding Reclassified to Loan Receivable |  | 0 |
Funding | 0 | 0 |
Adjustment to fair value | 0 |  |
Entity Consolidated |  | 0 |
Distribution | 0 | 0 |
Ending Balance | 13,660 | $ 12,738 | 11,992
Tag-6 Medical Investment Group, LLC* |  |  |
Schedule of Equity Method Investments [Line Items] |  |  |
% of Ownership |  | 100.00% |
Equity Method Investments [Roll Forward] |  |  |
Beginning Balance | $ 0 | $ 4,830 |
Allocation of Net Income (Loss) |  | 153 |
Funding Reclassified to Loan Receivable |  | 0 |
Funding |  | 1,435 |
Entity Consolidated |  | (6,418) |
Distribution |  | 0 |
Ending Balance |  | 0 | $ 4,830
Other |  |  |
Schedule of Equity Method Investments [Line Items] |  |  |
% of Ownership | 25.00% |  |
Equity Method Investments [Roll Forward] |  |  |
Beginning Balance | $ 0 |  |
Initial Investment | 325 |  |
Allocation of Net Income (Loss) | 232 |  |
Funding | 0 |  |
Adjustment to fair value | 0 |  |
Distribution | 0 |  |
Ending Balance | $ 557 | $ 0 |

X
- Definition Equity Method Investment, Additional Investment + References No definition available. + Details
Name: | asth_EquityMethodInvestmentAdditionalInvestment
Namespace Prefix: | asth_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Equity Method Investment, Adjustment To Fair Value + References No definition available. + Details
Name: | asth_EquityMethodInvestmentAdjustmentToFairValue
Namespace Prefix: | asth_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Equity Method Investment, Funding Reclassified to Loan Receivable + References No definition available. + Details
Name: | asth_EquityMethodInvestmentFundingReclassifiedToLoanReceivable
Namespace Prefix: | asth_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Equity Method Investments, Consolidated + References No definition available. + Details
Name: | asth_EquityMethodInvestmentsConsolidated
Namespace Prefix: | asth_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Equity Method Investments, Contribution + References No definition available. + Details
Name: | asth_EquityMethodInvestmentsContribution
Namespace Prefix: | asth_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Equity Method Investments + References No definition available. + Details
Name: | asth_EquityMethodInvestmentsRollForward
Namespace Prefix: | asth_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 323 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (a)(1) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3 + Details
Name: | us-gaap_EquityMethodInvestmentOwnershipPercentage
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition Amount of the entity's equity method investment which has been sold. + References No definition available. + Details
Name: | us-gaap_EquityMethodInvestmentSoldCarryingAmount
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 323 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org//1943274/2147481664/323-10-45-1 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 323 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (a)(3) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3 Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(10)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 25 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-25 + Details
Name: | us-gaap_EquityMethodInvestments
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Amount of income (loss) for proportionate share of equity method investee's income (loss). + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 45 -Paragraph 28 -Subparagraph (b) -SubTopic 10 -Topic 230 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 944 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-04(10)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 323 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org//1943274/2147481664/323-10-45-1 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 22 -Subparagraph (g) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22 Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03(12)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2 Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 942 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-04(13)(f)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1 + Details
Name: | us-gaap_IncomeLossFromEquityMethodInvestments
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(g)(1)(ii)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 323 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 825 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 28 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 323 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (a)(1) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 323 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (a)(2) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 323 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3 + Details
Name: | us-gaap_ScheduleOfEquityMethodInvestmentsLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=asth_LasalleMedicalAssociatesIpaMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=asth_PacificMedicalImagingAndOncologyCenterIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=asth_FiveThreeOneW.CollegeLLCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=asth_OneMSOLLCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=asth_CAIPAMSOMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=asth_Tag6MedicalInvestmentGroupLLCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=asth_OtherMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |